Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Berdeja, Jesus G.
Niesvizky, Ruben
Lonial, Sagar
Laubach, Jacob P.
Hamadani, Mehdi
Stewart, A. Keith
Hari, Parameswaran
Roy, Vivek
Vescio, Robert
Kaufman, Jonathan L.
Berg, Deborah
Liao, Eileen
Rajkumar, S. Vincent
Richardson, Paul G.
Funding for this research was provided by:
Millennium Pharmaceuticals, Inc. Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Article History
Received: 29 August 2018
Revised: 14 December 2018
Accepted: 24 December 2018
First Online: 29 January 2019
Compliance with ethical standards
:
: SKK: consulting fees, paid to institution, from Celgene, Takeda, Janssen, KITE, Merck, Abbvie, Medimmune, Genentech, Oncopeptides, and Amgen. JGB: institutional research funding from Abbvie, Amgen, Bluebird, BMS, Celgene, Genentech, Glenmark, Janssen, Novartis, Poseida, Takeda, and Teva. RN: membership of advisory council or committee, consulting fees, and grants or funds from Takeda, Celgene, BMS, Amgen, and Janssen. SL: personal fees as a consultant for Millennium Pharmaceuticals Inc., Celgene, Novartis, BMS, Onyx, and Janssen, outside the submitted work. MH: membership of advisory council or committee for Pharmacyclics and Medimmune, honoraria from Celgene and Sanofi, consulting fees from Cellerant, and grants or funds from Takeda and Otsuka. AKS: consultant for: Amgen, Celgene, BMS, Janssen, Ono, and Takeda. PH: membership of advisory council or committee, and honoraria from Millennium/Takeda and Celgene. RV: honoraria from Takeda. JLK: grant from Millennium Pharmaceuticals, Inc. during the conduct of the study. Grants from Celgene, Merck, and Novartis, and personal fees from Millennium Pharmaceuticals, Inc., Celgene, Onyx, Spectrum, Novartis, and Janssen, outside the conduct of the study. DB and EL: employment, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. PGR: consulting fees from Takeda and Celgene. The remaining authors declare that they have no conflict of interest.
: The study was performed in accordance with the International Conference on Harmonization, the Guidelines for Good Clinical Practice, appropriate regulatory requirements, and with approval of Institutional Review Boards at individual enrolling institutions.